AstraZeneca has reported positive outcomes from the BaxHTN Phase III trial, indicating that the highly selective aldosterone synthase inhibitor (ASI), baxdrostat, significantly reduced the mean seated ...

In the first placebo-controlled study of vaporized cannabis for acute migraine, patients report greater relief from pain and ...

Patients with knee osteoarthritis who received metformin demonstrated significant reductions in knee pain and increased ...

A 30-day course of antibiotics after robot-assisted radical cystectomy appears to eliminate UTIs and reduce costs of care.

Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, ...

An FDA-funded clinical trial found even modest CBD use triggered elevated liver enzymes in some healthy adults, raising ...

A motion sickness drug that treats severe depression in hours? Discover how scopolamine may revolutionize mental health ...

Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a open-label study ...

Discover a study that investigates a novel therapy for bladder pain syndrome using advanced trial designs to improve outcomes ...